Privia Health Group, Inc.
PRVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $580 | $521 | $480 | $461 |
| % Growth | 11.4% | 8.6% | 4.2% | – |
| Cost of Goods Sold | $519 | $473 | $434 | $413 |
| Gross Profit | $61 | $48 | $46 | $48 |
| % Margin | 10.5% | 9.1% | 9.5% | 10.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $40 | $38 | $32 | $34 |
| SG&A Expenses | $47 | $44 | $39 | $41 |
| Sales & Mktg Exp. | $7 | $7 | $7 | $6 |
| Other Operating Expenses | $0 | $0 | $2 | $2 |
| Operating Expenses | $47 | $44 | $41 | $43 |
| Operating Income | $14 | $3 | $5 | $5 |
| % Margin | 2.5% | 0.6% | 1.1% | 1.1% |
| Other Income/Exp. Net | $2 | $2 | $3 | $3 |
| Pre-Tax Income | $17 | $6 | $8 | $8 |
| Tax Expense | $7 | $2 | $2 | $3 |
| Net Income | $7 | $3 | $4 | $4 |
| % Margin | 1.2% | 0.5% | 0.9% | 1% |
| EPS | 0.06 | 0.022 | 0.03 | 0.037 |
| % Growth | 172.7% | -26.7% | -18% | – |
| EPS Diluted | 0.05 | 0.021 | 0.03 | 0.035 |
| Weighted Avg Shares Out | 123 | 122 | 121 | 120 |
| Weighted Avg Shares Out Dil | 129 | 128 | 128 | 126 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $3 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $3 | $2 | $2 |
| EBITDA | $19 | $8 | $7 | $7 |
| % Margin | 3.3% | 1.6% | 1.5% | 1.5% |